[Skip to Navigation]
Views 274
Citations 0
Comment & Response
September 2017

All Types of Hemorrhagic Stroke Are Not Created Equally

Author Affiliations
  • 1National University of Ireland, Galway, Ireland
  • 2Saolta University Health Care Group, Galway University Hospital, Galway, Ireland
JAMA Intern Med. 2017;177(9):1398-1399. doi:10.1001/jamainternmed.2017.3237

To the Editor The decision to initiate oral anticoagulation (OAC) posthemorrhagic stroke or traumatic intracerebral hemorrhage (ICH) in those with atrial fibrillation (AF) is a gray area in clinical practice. By showing that the decision to resume OAC may have a favorable risk-benefit ratio, the article by Nielsen et al1 published in a recent issue of JAMA Internal Medicine brings us closer to understanding if and when to do this. However, important questions remain, which may be difficult to clarify using such an observational approach.

Add or change institution